Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FMH9D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,058
Award facts
- Contract value 100% obligated
- $62,057.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $62,057.67. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA has demonstrated confidence in AmerisourceBergen's capabilities through multiple competitive awards across diverse therapeutic domains, and the company continues to compete for future regional contracts under the planned Pharmaceutical Prime Vendor Global Program Generation V initiative, which will involve multiple awards across separate geographic regions.
Quick answers
Who was awarded contract SPE2DR26FMH9D?
SPE2DR26FMH9D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FMH9D worth?
The government has obligated $62,058 on SPE2DR26FMH9D.
Is contract SPE2DR26FMH9D an order under another contract?
Yes. SPE2DR26FMH9D is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMH9D competed?
The extent of competition for SPE2DR26FMH9D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award